tradingkey.logo

Oramed Pharmaceuticals Inc <ORMP.OQ> expected to post a loss of 19 cents a share - Earnings Preview

ReutersAug 8, 2025 9:41 PM
  • Oramed Pharmaceuticals Inc ORMP.OQ ORMP.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Oramed Pharmaceuticals Inc is for a loss of 19 cents per share.

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated August 8 at 21:41 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI